PEOPLE - InnerDyne (US) makes promotion:
This article was originally published in Clinica
InnerDyne, a US developer and manufacturer of minimally invasive surgical access products, has announced the resignation of vice-president and chief financial officer Robert Stern. Mr Stern is leaving the company to pursue other business opportunities. President and CEO William Mavity will assume the CFO duties on an interim basis.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.